GLOBAL BLOOD THERAPEUTICS, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of December 17, 2021 1.875% Convertible Senior Notes due 2028Global Blood Therapeutics, Inc. • December 17th, 2021 • Pharmaceutical preparations • New York
INDENTURE dated as of December 17, 2021 between GLOBAL BLOOD THERAPEUTICS, INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and U.S. BANK NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee,” as more fully set forth in Section 1.01).
